|Day Low/High||78.31 / 80.94|
|52 Wk Low/High||65.25 / 92.64|
U.S. futures point a higher open following earnings beats from Amazon, Alphabet and Microsoft after the bell on Thursday.
Treasury secretary says it's baked into the market, but is anyone really counting on it?
Cambridge, Mass.-based KalVista Pharmaceuticals on Oct. 10 unveiled a collaboration pact with Merck.
There are plenty of reasons for the selloff, not the least of which is White House chaos.
Pressure is mounting on CEOs to step down from President Donald Trump's American Manufacturing Council
CEOs exit President's Council after Charlottesville response
North Korea says it will delay a decision on attacking Guam.
The problem for the pessimists is the same one that has plagued them since the election -- the price action is not cooperating.
Days after the deadly attack in Charlottesville, President Trump comes out with his strongest condemnation yet of the hate groups who rallied there.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Monday's trending stocks.
Merck CEO Ken Frazier is leaving Trump's business council.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Friday's trending stocks.
Merck , said today that its board of directors authorized a quarterly dividend of 47 cents
Stocks hold losses as a selloff in Snap pulls the rest of the tech sector lower.
The price momentum and money flow indicators of the drug maker are in positive alignment.
These three big stocks are teetering on the edge of breakout territory to start the month.
"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have I might be trading some of the earnings reports that will be released ...